Singapore, Singapore

Shen-Yi Ian Cheong

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Pathnova Laboratories Pte Ltd, Temasek Life Sciences Laboratory Limited, Temasek Life Sicences Laboratory Limited. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shen-Yi Ian Cheong. Retrieved from https://idiyas.com/inventor/shen-yi-ian-cheong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.9

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shen-Yi Ian Cheong: Innovator in Automated Disease Detection and Cancer Treatment

Introduction

Shen-Yi Ian Cheong is a notable inventor based in Singapore, recognized for his contributions to medical technology. He holds 2 patents that focus on innovative solutions for disease detection and cancer treatment. His work exemplifies the intersection of technology and healthcare, aiming to improve patient outcomes through advanced methodologies.

Latest Patents

One of Shen-Yi Ian Cheong's latest patents is an "Automated Disease Detection System." This invention provides a computer-implemented method for detecting diseases such as nasopharyngeal cancer (NPC). The system utilizes either a Fuzzy Inference (FI) system or a deep learning-fuzzy inference (DeLFI) hybrid model to analyze immunofluorescence assay (IFA) images. It distinguishes between Epstein Barr Virus (EBV) Early Antigen (EA) positive and negative cells, identifying cellular patterns indicative of NPC. The DeLFI hybrid model enhances scalability and accuracy while reducing the need for human evaluation.

Another significant patent is for "Hyperstabilized Liposomes Increase Targeting of Mitotic Cells." This invention involves hyperstable liposomes containing an anti-mitotic agent, which are designed to release the drug at a controlled rate. These liposomes are particularly useful in cancer treatment, specifically those comprising BI 2536 and citrate:phosphate in a 1:3 ratio. The slow release mechanism ensures effective targeting of mitotic cells, enhancing therapeutic efficacy.

Career Highlights

Shen-Yi Ian Cheong has worked with esteemed organizations such as Temasek Life Sciences Laboratory Limited. His experience in these institutions has contributed to his innovative research and development in the field of medical technology.

Collaborations

He has collaborated with notable colleagues, including Chang Zhi Adrian Ng and Sudipta Samanta. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Shen-Yi Ian Cheong's work in automated disease detection and cancer treatment showcases his commitment to advancing medical technology. His innovative patents reflect a dedication to improving healthcare outcomes through scientific research and collaboration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…